Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Jane M
    Senior Member
    • Aug 2011
    • 239

    Sequenza parameters

    Dear sequenza users,

    I am using Sequenza only recently. After the python script, I ran the 3 functions sequenza.extract(), sequenza.fit() and sequenza.results() with default parameters. My data is a set of 5 tumor-normal WES pairs.
    Now, I would like to adjust the parameters more precisely. The problem is that I do not clearly understand part of them, even after reading the vignette, the google group and the description of the R functions.

    Sorry for the long post, I do not know a lot sequenza and I am not an expert in segmentation.

    Here are the parameters:
    1) sequenza.extract
    • window=10^6
      "size of windows used when plotting mean and quartile ranges of depth ratios and B-allele frequencies. Smaller windows will take more time to compute"
      Is this parameter useful only for plotting?
      I changed it to 500 and I did not see changes when looking at the genome_view.pdf
    • overlap=1
      "integer specifying the number of overlapping windows"
      If we consider a specific window, it can overlap only 0, 1 or 2 window(s), right?
    • min.type.freq=0.9
      "minimum frequency of aberrant types"
      What does it mean?
    • weighted.mean=TRUE
      "boolean to select if the segments should be calculated using the read depth as weights to calculate depth ratio and B-allele frequency means"
      What does this mean?


    2) sequenza.fit
    • N.ratio.filter=10
      "Threshold of minimum number of observation of depth ratio in a segment"
      Minimum number of variants in a segment?
    • N.BAF.filter=1
      "threshold of minimum number of observation of B-allele frequency in a segment"
      Minimum number of variants in a segment?
      Why is the default value not the same as for N.ratio.filter?
    • segment.filter=3 10^6
      "threshold segment length (in base pairs) to filter out short segments, that can cause noise when fitting the cellularity and ploidy parameters. The threshold will not affect the allele-specific segmentation"
      Is it the minimum length of a segment?
      What is the usual range? 3 10^6 seems big.
    • ratio.priority=FALSE
      "logical, if TRUE only the depth ratio will be used to determine the copy number state, while the Bf value will be used to determine the number of B-alleles"
      Does this mean that with FALSE, both depth ratio and BAF will be use to determine copy number and only BAF to determine the number of B-alleles?


    My last concern is the gamma parameter, which seems crucial in segmentation.
    Since I have WES data, I chose breaks.method="full" and now I want to determine gamma.pcf and kmin.pcf.
    From what I understood, in cancer data, the range varies often from 15 to 40.
    I started with 40. From 140 to 40, copy number estimations did not change but 2/5 cellularity estimations changed: from 0.46 to 0.97 and from 0.35 to 0.26.
    Do you have a way to determine gamma?
    I will try to use the gamma.plot function of copynumber package.

    I am surprised to get very distant cellularities from what we believe. We are pretty sure to have high purity, most likely >90%, but sequenza returned range between 0.35 to 0.5 with default settings.
    Does someone get close values in its data?

    Sorry for the high number of questions!
    Thank you in advance for your feedback.
    Jane
  • Jane M
    Senior Member
    • Aug 2011
    • 239

    #2
    It seems that there are not a lot of sequenza users here.
    I will post also the question on the sequenza user google group. If someone is interested, an answer could be there.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM
    • GATTACAT
      Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
      by GATTACAT
      Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
      07-01-2026, 11:43 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    34 views
    0 reactions
    Last Post SEQadmin2  
    Working...